immunization clinical trials

New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study

This study is testing a new 'vaccine' for people with newly diagnosed glioblastoma, a type of brain cancer. It aims to see if it's safe and helps the body's immune system fight the cancer after standard treatments. This research could lead to bigger studies in the future.